YHYan-Fei He

Yan-Fei He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yan-Fei He has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Wang

    Health Management Center, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China

    4 shared publications
  • Xiao-Dong Hu

    Department of Endocrinology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China

    4 shared publications
  • Hu-Ming Li

    Department of Respiratory Medicine, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China

    3 shared publications
  • Jun-Qiang Liu

    Department of Thoracic Surgery, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China

    3 shared publications
  • Ni Wu

    Health Management Center, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China

    3 shared publications
  • Zhi-Gang Jiang

    Department of Statistics, Zunyi Medical University, Zunyi, China

    3 shared publications

Latest Publications

  • Open Access

    Single-port laparoscopic hernia needle therapy: New hope for the treatment of inguinal hernia in children

    by Yan-Fei He, Qin-Tong He

    The single-port laparoscopic hernia needle technique is gaining attention in the treatment of pediatric inguinal hernias due to its unique advantages. This editorial highlights the superiority and challenges of single-port laparoscopic hernia needles in the treatment of inguinal hernias in children. We hope that the study by Wang et al and this editorial will draw the attention of more physicians to the single-port laparoscopic hernia needle technique and promote its widespread use in the treatment of pediatric inguinal hernias.

  • Open Access

    Pancreatic primitive neuroectodermal tumors: Clinical features, treatment, and influencing factors

    by Yan-Fei He, Huan-Zhi Wang, Xiao-Dong Hu, Jun-Qiang Liu, Hu-Ming Li, Jie Wang, Shuang-Feng Lu

    BACKGROUND Data on clinical characteristics, treatment outcomes, and prognosis of pancreatic primitive neuroectodermal tumors (PNETs) are limited. AIM To analyze the clinical data of 30 patients with pancreatic PNETs to identify their clinical characteristics and factors associated with prognosis. METHODS We used the keywords "primary neuroectodermal tumor," "digestive tract," "pancreas," "pancreatic," and "gastrointestinal," individually or in combination, to collect data from a global database for all patients with pancreatic PNET to date. Univariate and Cox regression analyses were performed to identify prognostic factors for patient survival. RESULTS A total of 30 cases of pancreatic PNET were included in this study: 15 males and 15 females with a mean age of 24 years. The main symptom was abdominal pain (73.3%), and the median tumor size was 7.85 cm. Twenty-four patients (80.0%) underwent surgery and nineteen patients received adjuvant therapy. Local metastasis was observed in 13 patients (43.3%), lymph node metastasis in 10 patients (33.3%), and distant metastasis in 6 patients (20.0%). Local recurrence was observed in 13 patients (43.3%). The median survival time of all patients was 29.4 months, and the overall estimated 1-year and 3-year survival rates were approximately 66.0% and 36.4%, respectively. Univariate analysis showed that chemotherapy (P = 0.036), local metastasis (P = 0.041), lymph node metastasis (P = 0.003), distant metastasis (P = 0.049), and surgical margins (P = 0.048) were the prognostic factors affecting survival. Multivariate analysis revealed only lymph node metastasis (P = 0.012) as a prognostic factor. CONCLUSION Pancreatic PNET is extremely rare, occurs in young adults, has no apparent sex predisposition, has a high rate of metastasis and early recurrence, and has a very poor prognosis. The diagnosis of pancreatic PNET requires a combination of clinical symptoms, pathologic features, immunohistochemistry, and cytogenetic analysis. Univariate analysis suggested that chemotherapy, metastasis, and surgical margins were prognostic factors affecting survival, and multivariate analysis suggested that lymph node metastasis is an important prognostic factor. Therefore, early diagnosis, early and extensive resection, and adjuvant chemoradiotherapy may help improve prognosis.

  • Open Access

    Malignant melanoma: An important differential diagnosis for clear cell sarcoma of the gastrointestinal tract

    by Yan-Fei He

    A case report by Liu et al describes the characteristics of metastatic clear cell sarcoma (CCS) of the pancreas and provides valuable therapeutic insights for this rare malignancy. This case is interesting because of its rarity, suggesting that the pancreas may be a potential target organ for CCS, either primary or metastatic. At the same time, the authors also emphasize the importance of regular postopera tive follow-up for timely detection of recurrent lesions, as CCS is characterized by a high degree of malignancy and a high rate of recurrent metastases. Considering that CCS of the gastrointestinal tract is easily confused with malignant melanoma (MM) of the gastrointestinal tract, here we compare the clinical features, histopathological and immunohistochemical characteristics, diagnosis, treatment, and prognosis of CCS and MM of the gastrointestinal tract, hoping to provide a reference for clinical work.

  • Open Access

    Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges

    by Yan-Fei He

    Recently, the World Journal of Gastrointestinal Oncology published an article entitled “Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature”, in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu et al demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.

  • Open Access

    Bariatric surgery and diabetes: Current challenges and perspectives

    by Yan-Fei He, Xiao-Dong Hu, Jun-Qiang Liu, Hu-Ming Li, Shuang-Feng Lu

    Diabetes mellitus (DM) and obesity have become public issues of global concern. Bariatric surgery for the treatment of obesity combined with type 2 DM has been shown to be a safe and effective approach; however, there are limited studies that have systematically addressed the challenges of surgical treatment of obesity combined with DM. In this review, we summarize and answer the most pressing questions in the field of surgical treatment of obesity-associated DM. I believe that our insights will be of great help to clinicians in their daily practice.


  • Open Access

    Breastfeeding vs. breast milk transmission during COVID-19 pandemic, which is more important?

    by Yan-Fei He, Jun-Qiang Liu, Xiao-Dong Hu, Hu-Ming Li, Ni Wu, Jie Wang, Zhi-Gang Jiang

    The catastrophic coronavirus disease 2019 (COVID-19) pandemic has raised many health questions, and whether breast milk from SARS-CoV-2 infected mothers may be a vector for SARS-CoV-2 transmission has become a hot topic of concern worldwide. Currently, there are extremely limited and conflicting data on the risk of infection in infants through breastfeeding. For this reason, we investigated almost all current clinical studies and systematically analyzed the presence of SARS-CoV-2 and antibodies in the breast milk of mothers infected with SARS-CoV-2, their effects on newborns, and the mechanisms involved. A total of 82 studies were included in this review, of which 66 examined the presence of SARS-CoV-2 in breast milk samples from mothers diagnosed with COVID-19, 29 reported results of antibody detection of SARS-CoV-2 in breast milk, and 13 reported both nucleic acid and antibody test results. Seventeen studies indicated the presence of detectable SARS-CoV-2 nucleic acid in breast milk samples, and only two studies monitored viral activity, both of which reported that infectious viruses could not be cultured from RNA-positive breast milk samples. All 29 studies indicated the presence of at least one of the three antibodies, IgA, IgG and IgM, in breast milk. Five studies indicated the presence of at least one antibody in the serum of breastfed newborns. No COVID-19-related deaths were reported in all 1,346 newborns. Our study suggests that direct breastfeeding does not pose an additional risk of infection to newborns and that breast milk is a beneficial source of anti-SARS-CoV-2 antibodies that provide passive immune protection to infants. In addition, direct breastfeeding would provide maternal benefits. Our review supports the recommendation to encourage direct breastfeeding under appropriate infection control guidelines.Systematic Review Registration:https://www.crd.york.ac.uk/PROSPERO/#myprospero, identifier: 458043.


  • Open Access

    Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review

    by Yan-Fei He, Jing Ouyang, Xiao-Dong Hu, Ni Wu, Zhi-Gang Jiang, Ning Bian, Jie Wang

    Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review


  • Open Access

    Correlation between COVID-19 and hepatitis B: A systematic review

    by Yan-Fei He, Zhi-Gang Jiang, Ni Wu, Ning Bian, Jun-Lin Ren

    Correlation between COVID-19 and hepatitis B: A systematic review


  • Open Access

    Effect of COVID-19 on Male Reproductive System – A Systematic Review

    by Yanfei He, Jie Wang, Junlin Ren, Yubo Zhao, Jing Chen, Xuejiao Chen

    Background: Angiotensin-converting enzyme II (ACE2), a receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) to enter host cells, is widely expressed in testes and prostate tissues. The testis and prostate produce semen. At present, there are contradictory reports about whether SARS-CoV-2 can exist in the semen of infected men.Objective: To provide a comprehensive overview of the topic of whether COVID-19 can impact on male reproductive system.Methods: We reviewed the relevant publications on the possible impact of Coronavirus Disease 2019 (COVID-19) on male reproductive system and summarized the latest and most important research results so far. Literature published in English from December 2019 to January 31, 2021 regarding the existence of SARS-CoV-2 in semen, testis, and prostatic fluid and the effects of COVID-19 on male reproductive were included.Results: We identified 28 related studies, only one of which reported the presence of SARS-CoV-2 in semen. The study found that the semen quality of patients with moderate infection was lower than that of patients with mild infection and healthy controls. The impaired semen quality may be related to fever and inflammation. Pathological analysis of the testis/epididymis showed that SARS-CoV-2 viral particles were positive in 10 testicular samples, and the spermatogenic function of the testis was impaired. All 94 expressed prostatic secretion (EPS) samples were negative for SARS-CoV-2 RNA.Conclusion: The likelihood of SARS-CoV-2 in the semen of COVID-19 patients is very small, and semen should rarely be regarded as a carrier of SARS-CoV-2 genetic material. However, COVID-19 may cause testicular spermatogenic dysfunction via immune or inflammatory reactions. Long-term follow-up is needed for COVID-19 male patients and fetuses conceived during the father’s infection period.


  • THE CORRELATION BETWEEN PSYCHIATRIC DISORDERS AND COVID-19: A NARRATIVE REVIEW

    by Yanfei He, Ran Yu, Junlin Ren

    Since December 2019, the havoc caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has increased exponentially in a short period of time. As the COVID-19 pandemic is raging around the world, scientists are trying to reveal its mysteriousness. Although COVID-19 is predominantly a respiratory disease, the most common symptoms are fever, dry cough, and fatigue, but extrapulmonary manifestations are increasingly recognized. Recent studies have shown that there is a strong genetic correlation between one or more psychiatric disorders and the occurrence of SARS-CoV-2 infection. Historical epidemiological perspectives and recent neurobiological evidence link infection and psychosis. What is the relationship between COVID-19 and psychiatric disorders? In this article, we will review the correlation between COVID-19 and psychoses, the possible reasons, and the possible pathophysiological mechanisms. The purpose of this review is to provide a reference for clinicians to make correct judgment and treatment when facing patients with COVID-19 and/or psychiatric disorders.